Loading clinical trials...
Loading clinical trials...
This is a descriptive prospective community-based seroprevalence study. Primary objective: * To determine the prevalence of specific antibodies (immunoglobulin G \[IgG\]) against dengue in healthy 5...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sanofi Pasteur, a Sanofi Company
NCT06579755 · Dengue Fever
NCT04486638 · Dengue Virus Infection
NCT07007585 · Dengue, Dengue Fever, and more
NCT06665035 · Dengue Fever
NCT07040202 · Dengue, Sepsis
Kalyani, West Bengali
Bangalore
Hyderabad
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions